Lariciresinol - CAS 27003-73-2

Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.

TGF-beta/Smad, glycosidase, Antifection, Antifungal, Apoptosis, Bcl-2 Family, NF-κB, VEGFR

Tyrosine Kinase/Adaptors, Metabolism, Microbiology/Virology, Apoptosis, Stem Cells, Angiogenesis, NF-κB

26928

0.9984

C20H24O6

360.4

C(O)[C@@H]1[C@H](OC[C@@H]1CC2=CC(OC)=C(O)C=C2)C3=CC(OC)=C(O)C=C3

-20°C

Ice Packs

Natural Product